Migraine treatment with topiramate is linked to lower risks of end-stage kidney disease (ESKD), death, and ventricular arrhythmia/cardiac arrest, an investigator reported at the 62 nd European Renal ...

Second BTD Recognition Highlights Compound's Potential as Next-Generation Broad-Spectrum Renal Therapy SHANGHAI, June 26, 2025 /PRNewswire/ -- BioCity Biopharma ('BioCity') announced today that the ...

BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to ...

BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD ...

The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted BioCity's ...

Topline data also show that lorundrostat reduces albuminuria in hypertensive patients with CKD. Topline results from the phase 2 Explore-CKD trial show lorundrostat, an aldosterone synthase ...

Smartphone-based home screening significantly boosts chronic kidney disease (CKD) diagnosis and follow-up care, enhancing ...

BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to ...

Tom Nolan reviews this week’s research A diagnostic accuracy study of a blood test for colorectal cancer has some promising, if paradoxical, findings. The cell free DNA test had an overall sensitivity ...